The mission of the Japanese Clinical Association of Cannabinoids (JCAC) is to promote the exchange of knowledge on cannabinoids research and to contribute to medical care and the welfare of people in Japan.
Targeting the Japanese medical professional community, JCAC was established in September 2015 launching its first publication: The Science of Cannabinoids (Tsukiji Shokan publisher). JCAC holds academic conferences twice annually, in the spring and fall, and since 2016 has been partnered with the International Association for Cannabinoid Medicines ( IACM).
Beginning in 2020, JCAC is proud to have engaged the expertise of Medical Marijuana 411 to provide a certified program to JCAC members based on MM411’s fundamental cannabinoid medicine and fundamental cannabidiol courses.